Dr. Steven O'day, M.D

NPI: 1518070812
Total Payments
$594,773
2022 Payments
$2,100
Companies
16
Transactions
486
Medicare Patients
204
Medicare Billing
$29,763

Payment Breakdown by Category

Other$393,948 (66.2%)
Consulting$98,755 (16.6%)
Travel$94,554 (15.9%)
Food & Beverage$7,496 (1.3%)
Education$20.67 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $391,448 114 65.8%
Consulting Fee $98,755 41 16.6%
Travel and Lodging $94,554 159 15.9%
Food and Beverage $7,496 168 1.3%
Honoraria $2,500 1 0.4%
Education $20.67 3 0.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $530,006 373 $0 (2022)
Merck Sharp & Dohme Corporation $34,867 60 $0 (2020)
Eisai Co., Ltd. $13,750 3 $0 (2020)
Millennium Pharmaceuticals, Inc. $7,420 6 $0 (2017)
Incyte Corporation $4,837 7 $0 (2017)
ARRAY BIOPHARMA INC $2,617 12 $0 (2021)
Celgene Corporation $662.57 4 $0 (2022)
Novartis Pharmaceuticals Corporation $197.69 6 $0 (2019)
Genentech USA, Inc. $107.02 6 $0 (2018)
Amgen Inc. $103.92 3 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $2,100 6 E.R. Squibb & Sons, L.L.C. ($1,500)
2021 $4,462 3 ARRAY BIOPHARMA INC ($2,500)
2020 $118,075 63 E.R. Squibb & Sons, L.L.C. ($100,308)
2019 $145,209 113 E.R. Squibb & Sons, L.L.C. ($128,409)
2018 $142,495 131 E.R. Squibb & Sons, L.L.C. ($131,245)
2017 $182,432 170 E.R. Squibb & Sons, L.L.C. ($166,594)

All Payment Transactions

486 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
06/15/2022 Celgene Corporation Consulting Fee Cash or cash equivalent $300.00 General
06/15/2022 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $300.00 General
06/15/2022 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $300.00 General
04/13/2022 Celgene Corporation Consulting Fee Cash or cash equivalent $300.00 General
04/13/2022 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $300.00 General
03/21/2022 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $600.00 General
06/01/2021 Gilead Sciences, Inc. Education In-kind items and services $11.92 General
02/19/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Consulting Fee Cash or cash equivalent $1,950.00 General
Category: Oncology
01/07/2021 ARRAY BIOPHARMA INC BRAFTOVI (Drug) Honoraria Cash or cash equivalent $2,500.00 General
Category: ONCOLOGY
12/14/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
12/14/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
12/08/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
12/08/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $630.00 General
Category: Oncology
12/03/2020 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $22.59 General
Category: ONCOLOGY
12/01/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
12/01/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
11/12/2020 Eisai Co., Ltd. Lenvima (Drug) Consulting Fee Cash or cash equivalent $2,500.00 General
Category: Oncology
10/29/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
10/27/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,070.00 General
Category: Oncology
10/27/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
10/23/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Consulting Fee Cash or cash equivalent $1,950.00 General
Category: Oncology
10/20/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
10/13/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
10/06/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Oncology
10/02/2020 Eisai Co., Ltd. Lenvima (Drug) Consulting Fee Cash or cash equivalent $6,250.00 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 3 204 392 $179,872 $29,763
Total Patients
204
Total Services
392
Medicare Billing
$29,763
Procedure Codes
3

All Medicare Procedures & Services

3 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 118 273 $105,378 $17,307 16.4%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 52 85 $46,410 $7,622 16.4%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 34 34 $28,084 $4,835 17.2%

About Dr. Steven O'day, M.D

Dr. Steven O'day, M.D is a Hematology & Oncology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518070812.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven O'day, M.D has received a total of $594,773 in payments from pharmaceutical and medical device companies, with $2,100 received in 2022. These payments were reported across 486 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($391,448).

As a Medicare-enrolled provider, O'day has provided services to 204 Medicare beneficiaries, totaling 392 services with total Medicare billing of $29,763. Data is available for 1 year (2020–2020), covering 3 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Santa Monica, CA
  • Active Since 08/17/2006
  • Last Updated 03/07/2023
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1518070812

Products in Payments

  • OPDIVO (Biological) $399,857
  • Lenvima (Drug) $13,750
  • ENTYVIO (Biological) $7,420
  • KEYTRUDA (Biological) $3,637
  • BRAFTOVI (Drug) $2,500
  • LENVIMA (Drug) $1,813
  • MK-7339 (Drug) $152.97
  • MEKINIST (Drug) $143.70
  • Braftovi (Drug) $116.58
  • PHASIX (Device) $94.51
  • Nplate (Biological) $67.66
  • TECENTRIQ (Biological) $46.08
  • KISQALI (Drug) $45.57
  • IMLYGIC (Biological) $36.26
  • Xtandi (Drug) $31.22
  • ZOLADEX (Drug) $26.42
  • LIBTAYO (Biological) $24.11
  • Avastin (Biological) $21.91
  • Alecensa (Biological) $20.16
  • Herceptin (Biological) $18.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Santa Monica